{"id":61940,"date":"2015-12-07T10:00:41","date_gmt":"2015-12-07T15:00:41","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=61940"},"modified":"2015-12-07T19:20:02","modified_gmt":"2015-12-08T00:20:02","slug":"write-his-way-out","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2015\/12\/07\/write-his-way-out\/","title":{"rendered":"write his way out&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\" class=\"big\"><a href=\"http:\/\/www.statnews.com\/pharmalot\/2015\/12\/03\/drug-price-martin-shkreli-daraprim-turing-pharmaceuticals\/\" target=\"_blank\">Unrepentant and brash, Martin Shkreli defends Daraprim pricing<\/a><\/div>\n<div align=\"center\" class=\"big-content\"><strong><font color=\"#200020\">Martin Shkreli remains as unrepentant as ever<\/font><\/strong><\/div>\n<div align=\"center\" class=\"big\"><strong><font color=\"#004400\"><span class=\"category-title\">Pharmalot<\/span><\/font><\/strong><\/div>\n<div align=\"center\" class=\"middle>By Ed Silverman<\/div>\n<div align=\">December 3, 2015<\/div>\n<p align=\"justify\">In a brief, but illuminating appearance at a health industry gathering on  Thursday, the controversial chief executive of Turing Pharmaceuticals  rejected fresh criticism that he went back on his promise to lower the  price of the life-saving medicine Daraprim.<\/p>\n<p align=\"justify\">&ldquo;Our shareholders expect us to make as much as money as possible,&rdquo;  said a defiant Shkreli, who wore a hooded sweatshirt and sneakers in an  auditorium that was otherwise filled with buttoned-down executives,  physicians, and investors. &ldquo;That&rsquo;s the ugly, dirty truth.&rdquo;<\/p>\n<div align=\"justify\"> Shkreli was responding to questions about his recent decision to  leave intact the $750-a-tablet list price for Daraprim. Turing bought  the drug last summer and quickly jacked up the price from $13.55, a  5,000 percent increase that became a flashpoint in the debate over  prescription drug costs&#8230;<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\"><img decoding=\"async\" vspace=\"4\" hspace=\"5\" height=\"180\" border=\"0\" align=\"right\" src=\"http:\/\/1boringoldman.com\/images\/genet.gif\" \/>While it is unlikely that Martin Shkreli will ever be canonized like <a href=\"https:\/\/en.wikipedia.org\/wiki\/Jean_Genet\" target=\"_blank\">Jean Genet<\/a> was by Jean Paul Sartre for his authenticity, Shkreli&#8217;s &ldquo;<font color=\"#200020\">ugly, dirty truth<\/font>&rdquo; that &ldquo;<font color=\"#200020\">Our shareholders expect us to make as much as money as possible<\/font>&rdquo; is refreshingly honest after the decades of spin. The drug in question, Daraprim, is almost exclusively used in the treatment of the Toxoplasmosis infections seen in immunologic compromised patients, primarily people with AIDS. And to my knowledge, there&#8217;s no justification for Shkreli&#8217;s breathtaking price hike other than those given above. <\/div>\n<p><\/p>\n<div align=\"justify\" class=\"small\">After a life of crime, Jean Genet was languishing in a French prison when he began to write. He was ultimately liberated from prison for his brilliance by the likes of  Jean-Paul Sartre and Pablo Picasso. He went on to become a commanding presence in the literature of 20th century, and he never returned to prison. I find myself thinking that we should afford Martin  Shkreli the same opportunity. Lock him up, and see if he can write his way out&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Unrepentant and brash, Martin Shkreli defends Daraprim pricing Martin Shkreli remains as unrepentant as ever Pharmalot December 3, 2015 In a brief, but illuminating appearance at a health industry gathering on Thursday, the controversial chief executive of Turing Pharmaceuticals rejected fresh criticism that he went back on his promise to lower the price of the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-61940","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/61940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=61940"}],"version-history":[{"count":18,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/61940\/revisions"}],"predecessor-version":[{"id":61989,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/61940\/revisions\/61989"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=61940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=61940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=61940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}